We also report novel data suggesting that HCCs arising in patients with ALD&NAFLD homozygous for the 148M PNPLA3 allele present earlier during the natural history of cirrhosis, are less differentiated, and have a larger diffusion at presentation, and a worse prognosis. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.